LRRC6 Antikörper (AA 1-466)
-
- Target Alle LRRC6 Antikörper anzeigen
- LRRC6 (Leucine Rich Repeat Containing 6 (LRRC6))
-
Bindungsspezifität
- AA 1-466
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LRRC6 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Verwendungszweck
- Mouse polyclonal antibody raised against a full-length human LRRC6 protein.
- Sequenz
- MGWITEDLIR RNAEHNDCVI FSLEELSLHQ QEIERLEHID KWCRDLKILY LQNNLIGKIE NVSKLKKLEY LNLALNNIEK IENLEGCEEL AKLDLTVNFI GELSSIKNLQ HNIHLKELFL MGNPCASFDH YREFVVATLP QLKWLDGKEI EPSERIKALQ DYSVIEPQIR EQEKDHCLKR AKLKEEAQRK HQEEDKNEDK RSNAGFDGRW YTDINATLSS LESKDHLQAP DTEEHNTKKL DNSEDDLEFW NKPCLFTPES RLETLRHMEK QRKKQEKLSE KKKKVKPPRT LITEDGKALN VNEPKIDFSL KDNEKQIILD LAVYRYMDTS LIDVDVQPTY VRVMIKGKPF QLVLPAEVKP DSSSAKRSQT TGHLVICMPK VGEVITGGQR AFKSMKTTSD RSREQTNTRS KHMEKLEVDP SKHSFPDVTN IVQEKKHTPR RRPEPKIIPS EEDPTFEDNP EVPPLI
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody reactive against mammalian transfected lysate.
- Immunogen
- LRRC6 (NP_036604.2, 1 a.a. ~ 466 a.a) full-length human protein.
- Top Product
- Discover our top product LRRC6 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- In 1x PBS, pH 7.4
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
- Target
- LRRC6 (Leucine Rich Repeat Containing 6 (LRRC6))
- Andere Bezeichnung
- LRRC6 (LRRC6 Produkte)
- Synonyme
- LRTP antikoerper, Lrtp antikoerper, Tslrp antikoerper, CILD19 antikoerper, TSLRP antikoerper, lrrc6l antikoerper, leucine rich repeat containing 6 (testis) antikoerper, leucine rich repeat containing 6 antikoerper, Lrrc6 antikoerper, LRRC6 antikoerper, lrrc6 antikoerper
- Hintergrund
-
Full Gene Name: leucine rich repeat containing 6
Synonyms: LRTP,TSLRP - Gen-ID
- 23639
- NCBI Accession
- NM_012472
- Pathways
- M Phase
-